Centro Oftalmológico Dr. Charles S.A.
Capital Federal, Argentina
Eye care center in Buenos Aires
C1116ABA Ciudad Autónoma de Buenos Aires AR, Riobamba 841, C1116 ABA
About Centro Oftalmológico Dr. Charles S.A.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
8
Clinical Trials at Centro Oftalmológico Dr. Charles S.A.
During the past decade, Centro Oftalmológico Dr. Charles S.A. conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 1 clinical trials were completed, i.e. on
average, 12.5% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 1 clinical trials were completed. i.e. 14.3%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Neovascular Age-Related Macular Degeneration (LUCERNE)
2019-03-11
2022-01-07
Completed
658
A Study to Investigate Aqueous Humor and Multimodal Imaging Biomarkers in Treatment-Naïve Participants With Diabetic Macular Edema Treated With Faricimab
2020-12-01
2022-12-22
Completed
99
A Study of the Efficacy, Safety, and Pharmacokinetics of A 36-Week Refill Regimen for the Port Delivery System With Ranibizumab in Patients With Neovascular Age-Related Macular Degeneration (Velodrome)
2021-07-14
2024-05-15
Recruiting
442
A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Macular Edema Secondary to Branch Retinal Vein Occlusion
2021-03-02
2023-06-15
Active, not recruiting
553
A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Macular Edema Secondary to Central Retinal or Hemiretinal Vein Occlusion
2021-03-02
2023-07-13
Active, not recruiting
729
A Study to Evaluate the Long-Term Safety and Tolerability of Faricimab in Participants With Neovascular Age-Related Macular Degeneration
2021-04-19
2024-08-09
Active, not recruiting
1,036
A Study to Investigate RO7200220 in Diabetic Macular Edema
2021-12-31
2025-05-31
Recruiting
400
A Study to Investigate RO7200220 in Combination With Ranibizumab in Diabetic Macular Edema
2021-12-17
2024-09-30
Recruiting
230
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Centro Oftalmológico Dr. Charles S.A."
#1 collaborator was "Chugai Pharmaceutical" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Centro Oftalmológico Dr. Charles S.A.
According to Clinical.Site data, the most researched conditions in "Centro Oftalmológico Dr. Charles S.A." are
"Diabetic Macular Edema" (3 trials), "Macular Edema" (2 trials), "Branch Retinal Vein Occlusion" (1 trials), "Central Retinal Vein Occlusion" (1 trials) and "Hemiretinal Vein Occlusion" (1 trials). Many other conditions were trialed in "Centro Oftalmológico Dr. Charles S.A." in a lesser frequency.
Clinical Trials Intervention Types at Centro Oftalmológico Dr. Charles S.A.
Most popular intervention types in "Centro Oftalmológico Dr. Charles S.A." are "Drug" (8 trials), "Other" (3 trials), "Procedure" (3 trials) and "Device" (1 trials). Other intervention types were less common.
The name of intervention was led by "Sham Procedure" (6 trials), "Faricimab" (5 trials), "Aflibercept" (3 trials), "Ranibizumab" (3 trials) and "RO7200220" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Centro Oftalmológico Dr. Charles S.A.
The vast majority of trials in "Centro Oftalmológico Dr. Charles S.A." are
8 trials for "All" genders.
Clinical Trials Status at Centro Oftalmológico Dr. Charles S.A.
Currently, there are NaN active trials in "Centro Oftalmológico Dr. Charles S.A.".
undefined are not yet recruiting,
3 are recruiting,
3 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Centro Oftalmológico Dr. Charles S.A.,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Centro Oftalmológico Dr. Charles S.A., 0 "Phase 1"
clinical trials were conducted, 3 "Phase 2" clinical
trials and 5 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".